Gonadal hormone levels and platelet tryptophan and serotonin concentrations in perimenopausal women with or without depressive symptoms

Gynecological Endocrinology

Volumn 30, Issue 3, 2014, Pages 232-235

  Flores Ramos, Mónica ^a   Moreno, Julia ^b   Heinze, Gerhard ^c   Aguilera Pérez, Rafael ^a   Pellicer Graham, Francisco ^b  

^a INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

^b INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Depressive disorder; Gonadal hormones; Perimenopause; Tryptophan

Indexed keywords

ANXIETY; BLOOD PLATELETS; DEPRESSION; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GONADAL HORMONES; HOT FLASHES; HUMANS; MEXICO; MIDDLE AGED; PERIMENOPAUSE; PSYCHIATRIC STATUS RATING SCALES; SELF REPORT; SEROTONIN; SEVERITY OF ILLNESS INDEX; SLEEP INITIATION AND MAINTENANCE DISORDERS; TRYPTOPHAN;

EID: 84894568972     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2013.875994     Document Type: Article

References (39)

1. Stewart DE, Boydell KM. Psychological distress during menopause: associations across the reproductive life cycle. Int J Psychiatry Med 1993;23:157-62.
2. Pimenta F, Leal I, Maroco J, Ramos C. Menopausal symptoms: do life events predict severity of symptoms in peri and postmenopause? Maturitas 2012;72:324-31.
3. Shaver JL, Paulsen VM. Sleep, psychological distress, and somatic symptoms in perimenopausal women. Fam Pract Res J 1993;13: 373-84.
4. Maartens LW, Knottnerus JA, Pop VJ. Menopausal transition and increased depressive symptomatology: a community based prospective study. Maturitas 2002;42:195-200.
5. Chedraui P, San Miguel G, Avila C. Quality of life impairment during the female menopausal transition is related to personal and partner factors. Gynecol Endocrinol 2009;25:130-5.
6. Cohen LS, Soares CN, Vitonis AF, et al. Risk for new onset of depression during the menopausal transition. The Harvard Study of Mood and Cycles. Arch Gen Psychiatry 2006;63:385-90.
7. Bromberger JT, Matthews KA, Schott LL, et al. Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN). J Affect Disord 2007;103:267-72.
8. Freeman EW, Sammel MD, Liu L, et al. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004;61:62-70.
9. Bromberger JT, Schott LL, Kravitz HM, et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN). Arch Gen Psychiatry 2010;67:598-607.
10. Schmidt PJ, Haq N, Rubinow DR. A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry 2004;161:2238-44.
11. Rubinow DR, Schmidt PJ, Roca CA. Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry 1998; 44:839-50.
12. Joffe H, Cohen LS. Estrogen, serotonin and mood disturbance: where is the therapeutic bridge? Biol Psychiatry 1998;44:798-811.
13. Osterlund MK, Hurd YL. Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog Neurobiol 2001; 64:251-67.
14. Deecher D, Andree T, Sloan D, Schechter LE. From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology 2008;33:3-17.
15. Schmidt PJ, Rubinow DR. Menopause-related affective disorders: a justification for further study. Am J Psychiatry 1991;148:844-52.
16. Campbell S, Whitehead M. Oestrogen therapy and the menopause syndrome. Clin Obstet Gynaecol 1977;4:31-47.
17. Studd J. Why are estrogens rarely used for the treatment of depression in women? Gynecol Endocrinol 2007;23:63-4.
18. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind randomized, placebo-controlled trial. Arch Gen Psychiatry 2001;58:529-34.
19. Yazici K, Pata O, Yazici A, et al. The effects of hormone in menopause on symptoms of anxiety and depression. Turk Psikyatri Derg 2003;14:10-15.
20. Schmidt PJ, Roca CA, Bloch M, Rubinow DR. The perimenopause and affective disorders. Semin Reprod Endocrinol 1997;15: 91-100.
21. Joffe H, Fagioli L, Koukopoulos A, et al. Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition. J Clin Endocrinol Metab 2011;96:E1044-54.
22. Masten WG, Caldwell-Colbert AT, Alcala SJ, Mijares BE. Confiabilidad y validez de la Escala de Depresio'n del Centro de Estudios Epidemiolo'gicos. Hisp J Behav Sci 1986;8:77-84.
23. Manber R, Blasey C, Arnow B, et al. Assessing insomnia severity in depression: comparison of depression rating scales and sleep diaries. J Psychiatr Res 2005;39:481-8.
24. Gundlah C, Lu NZ, Bethea CL. Ovarian steroid regulation of monoamine oxidase-A and -B mRNA and binding levels in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology (Berl) 2002;160:271-82.
25. Hiroi R, McDevitt RA, Neumaier JF. Estrogen selectively increases tryptophan hydroxylase-2 mRNA expression in distinct subregions of rat midbrain raphe nucleus: association between gene expression and anxiety behavior in the open field. Biol Psychiatry 2006;60: 288-95.
26. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood women with no history of depression. Arch Gen Psychiatry 2006;63:375-82.
27. Schmidt PJ, Murphy JH, Haq N, et al. Basal plasma hormone levels in depressed perimenopausal women. Psychoneuroendocrinology 2002;27:907-20.
28. Freeman EW, Sammel MD, Lin H, et al. Symptoms in the menopausal transition: hormone and behavior correlates. Obstet Gynecol 2008;111:127-36.
29. Weiner CL, Primeau M, Hermann DA. Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls. Psychosom Med 2004;66: 356-62.
30. Afsar B. Relationship between total testosterone, cognitive function, depressive behavior, and sleep quality in chronic kidney disease patients not on dialysis. Clin Exp Nephrol 2013;17:59-65.
31. Miller CM, Rindflesch TC, Fiszman M, et al. A closed literaturebased discovery technique finds a mechanistic link between hypogonadism and diminished sleep quality in aging men. Sleep 2012;35:279-85.
32. Sowers MF, Zheng H, Kravitz HM, et al. Sex steroid hormone profiles are related to sleep measures from polysomnography and the Pittsburgh sleep quality index. Sleep 2008;31:1339-49.
33. Riemann D, Feige B, Hornyak M, et al. The tryptophan depletion test: impact on sleep in primary insomnia - a pilot study. Psychiatry Res 2002;109:129-35.
34. Hudson C, Hudson SP, Hecht T, MacKenzie J. Protein source tryptophan versus pharmaceutical grade tryptophan as an efficacious treatment for chronic insomnia. Nutr Neurosci 2005;8:12-17.
35. Harada T, Hirotani M, Maeda M, et al. Correlation between breakfast tryptophan content and morningness-eveningness in Japanese infants and students aged 0-15 years. J Physiol Anthropol 2007;26:201-7.
36. National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med 2005;142:1003-13.
37. Baglioni C, Battagliese G, Feige B, et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord 2011;135:10-19.
38. Young T, Rabago D, Zgierska A, et al. Objective and subjective sleep quality in premenopausal, perimenopausal, and postmenopausal women in the Wisconsin Sleep Cohort Study. Sleep 2003;26: 667-72.
39. Thurston RC, Santoro N, Matthews KA. Are vasomotor symptoms associated with sleep characteristics among symptomatic midlife women? Comparisons of self-report and objective measures. Menopause 2012;19:742-8.